ARTICLE | Clinical News
Actelion announces positive Phase III data
May 2, 2000 7:00 AM UTC
Actelion (SWX:ATLN) said it showed that treatment with its bosentan improved hemodynamics and increased exercise capacity in advanced pulmonary hypertension patients. The international, double-blind s...